Access the full text.
Sign up today, get DeepDyve free for 14 days.
C. Bouza, M. Angeles, A. Muñoz, J. Amate (2004)
Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review.Addiction, 99 7
T. Mark, H. Kranzler, Xue-zhu Song, P. Bransberger, Virginia Poole, Scott Crosse (2003)
Physicians' opinions about medications to treat alcoholism.Addiction, 98 5
BF Grant, DA Dawson, FS Stinson, SP Chou, MC Dufour, RP Pickering
The 12-month prevalence and trends in DSM-IValcohol abuse and dependence: United States, 1991-1992 and 2001-2002.
B. Grant, D. Dawson, F. Stinson, S. Chou, M. Dufour, R. Pickering (2004)
The 12-Month Prevalence and Trends in DSM–IV Alcohol Abuse and DependenceAlcohol Research & Health, 29
R. Anton, S. O'Malley, D. Ciraulo, R. Cisler, D. Couper, D. Donovan, D. Gastfriend, J. Hosking, B. Johnson, J. Locastro, R. Longabaugh, B. Mason, M. Mattson, W. Miller, H. Pettinati, C. Randall, R. Swift, R. Weiss, L. Williams, A. Zweben (2006)
Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.JAMA, 295 17
S. Rösner, Andrea Hackl-Herrwerth, S. Leucht, S. Vecchi, M. Srisurapanont, M. Soyka (2010)
Opioid antagonists for alcohol dependence.The Cochrane database of systematic reviews, 1
H. Kranzler (2000)
Medications for alcohol dependence--new vistas.JAMA, 284 8
COMMENTARY/EDITORIALS 8. Mendelsohn AB, Governale L, Trontell A, Seligman P. Changes in isotretinoin 14. US General Accounting Office. FDA Drug Review: Postapproval Risks 1976-85. prescribing before and after implementation of the System to Manage Accutane Washington, DC: US General Accounting Office; April 1990:24. Publication GAO/ Related Teratogenicity (SMART) risk management program. Pharmacoepidemiol PEMD-90-15. Drug Saf. 2005;14:615-618. 15. Lasser KE, Allen PD, Woolhandler SJ, Himmelstein DU, Wolfe SM, Bor DH. 9. Leape LL, Brennan TA, Laird N, et al. The nature of adverse events in hospi- Timing of new black box warnings and withdrawals for prescription medications. talized patients: results of the Harvard Medical Practice Study II. N Engl J Med. JAMA. 2002;287:2215-2220. 1991;324:377-384. 16. Bakke OM, Manocchia M, de Abajo F, Kaitin KI, Lasagna L. Drug safety dis- 10. Rawlins MD, Thompson JW. Pathogenesis of adverse drug reactions. In: Dav- continuations in the United Kingdom, the United States, and Spain from 1974 ies DM, ed. Textbook of Adverse Drug Reactions. Oxford, England: Oxford Uni- through 1993: a regulatory perspective. Clin Pharmacol Ther. 1995;58:108-117. versity Press; 1977:44. 17. Halpin TJ, Holtzhauer FJ, Campbell RJ, et al. Reye’s syndrome and medica- 11. Califf RM. The need for a national infrastructure to
JAMA – American Medical Association
Published: May 3, 2006
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.